Debt outstanding
$160M
200 SIDNEY ST
200 Sidney Street · Cambridge, MA 02139
Every loan the CMBS tape reports against this building, as each trust filed it. A
building is the grain here, not the loan: this one is collateral in
4 separate trusts,
and the slices below are the pieces of its debt, not four different buildings.
Loan slices
5
Trusts
4
Type
Mixed Use
Square feet
188,616
Year built
2000 · renovated 2016
Where the filings differ
Each trust describes the building in its own filing, and these are the fields on
which they do not match. Both spellings are printed with the trust that filed each. Often both
are true — a building sits in one municipality and takes its mail in another — and
where one is simply a misspelling, we do not have a basis to say which.
Square feet
188,616 — Benchmark 2024-V10 Mortgage Trust; BANK5 2024-5YR9; BBCMS Mortgage Trust 2024-5C29; Wells Fargo Commercial Mortgage Trust 2024-5C2
995,458 — BBCMS Mortgage Trust 2024-5C29
The debt, slice by slice
| Trust | Balance | Rate | Matures | DSCR | NOI | Occupancy | Originator | Servicer | Special servicing |
|---|---|---|---|---|---|---|---|---|---|
| Benchmark 2024-V10 Mortgage Trust · asset 1 | $74M | 5.49% fixed | 2029-08-09 | — | — | — | Goldman Sachs Bank USA | KeyBank Real Estate Capital | No |
| BANK5 2024-5YR9 · asset 4-001 | $40M | 5.49% fixed | 2029-08-09 | 1.91 | $59M | 100% | Wells Fargo Bank, N.A. | KeyBank Real Estate Capital | No |
| BBCMS Mortgage Trust 2024-5C29 · asset 8A-5-A-2 | $27M | 5.43% fixed | 2029-08-09 | 1.37 | $59M | 100% | Citi Real Estate Funding Inc. | KeyBank Real Estate Capital | No |
| Wells Fargo Commercial Mortgage Trust 2024-5C2 · asset 17-001 | $16M | 5.49% fixed | 2029-08-09 | 1.91 | $59M | 100% | Goldman Sachs Bank USA | KeyBank Real Estate Capital | No |
| BBCMS Mortgage Trust 2024-5C29 · asset 8A-5-B-2 | $3M | 5.92% fixed | 2029-08-09 | 1.37 | $59M | — | Citi Real Estate Funding Inc. | KeyBank Real Estate Capital | No |
Named tenants
| Tenant | Square feet | Lease expires |
|---|---|---|
| AbbVie Inc. | 119,980 | 2028-07-31 |
| Seres Therapeutics, Inc. | 68,636 | 2030-01-13 |
| Intellia Therapeutics, Inc | 65,319 | 2026-09-30 |
The asset-level exhibit names up to three tenants per
slice; where the trusts name different ones, all of them are listed.
- Built from SEC Regulation AB II asset-level filings (Form ABS-EE, Item 1(a) exhibits) as filed by each trust’s depositor. Latest filing on this building: 2026-08-28.
- Rebuilt nightly. A slice that left its pool is excluded by the tape’s own latest-filing cut, so this page shows live debt only.
- Figures are as each trust filed them and are not restated, reconciled or scored here.
See the whole picture, not just the pulse.
Metro Pulse is the free, public read. The Verstavo platform goes loan‑by‑loan — stress
scores, maturity walls, special‑servicing transfers, bank CRE, and your own portfolio benchmarked
against the market.